Glucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes.

This document provides comprehensive information on glucose monitoring and control testing for individuals with Type 1 or Type 2 diabetes. It discusses the importance of regular glucose measurements for monitoring therapy and assessing long-term risks. The document covers different methods of glucose measurement, including self-measurement of capillary blood glucose concentration (SMBG) and continuous glucose monitoring (CGM). It emphasizes the need for proper training and supervision in using CGM systems and highlights the benefits of CGM for children with Type 1 diabetes. The document also provides recommendations on using SMBG for different diabetes types and therapies. Additionally, it discusses the frequency of blood glucose measurements for different types of diabetes and therapy approaches. The document addresses the importance of self-measurement of capillary blood glucose concentration (SMBG) in patients with type 1 or insulin-dependent type 2 diabetes, even if a continuous glucose monitoring (CGM) system is used. The frequency of measurements varies depending on the type of diabetes and therapy approach. The document also provides information on self-measurement of blood glucose (SMBG) and continuous glucose monitoring (CGM) for individuals with diabetes. It emphasizes the importance of regular glucose measurements for proper diabetes management and discusses the different measurement methods, available systems, and specifications for measurement quality. The document also addresses the costs and refund of expenses for SMBG systems, as well as safety issues and practical implementation of the measurement. It highlights the use of CGM systems and the goals and indications for their use [Extracted from the article]